CA954512A - 5-phenyl-tetrazole derivatives - Google Patents

5-phenyl-tetrazole derivatives

Info

Publication number
CA954512A
CA954512A CA069,922A CA69922A CA954512A CA 954512 A CA954512 A CA 954512A CA 69922 A CA69922 A CA 69922A CA 954512 A CA954512 A CA 954512A
Authority
CA
Canada
Prior art keywords
phenyl
tetrazole derivatives
tetrazole
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA069,922A
Other languages
English (en)
Inventor
Alfred Popelak
Ansgar Lerch
Kurt Stach
Egon Roesch
Klaus Hardebeck
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roche Diagnostics GmbH
Original Assignee
Boehringer Mannheim GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim GmbH filed Critical Boehringer Mannheim GmbH
Application granted granted Critical
Publication of CA954512A publication Critical patent/CA954512A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
CA069,922A 1968-12-20 1969-12-15 5-phenyl-tetrazole derivatives Expired CA954512A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE1815922A DE1815922C3 (de) 1968-12-20 1968-12-20 5-Phenyltetrazol-Derivate

Publications (1)

Publication Number Publication Date
CA954512A true CA954512A (en) 1974-09-10

Family

ID=5716852

Family Applications (1)

Application Number Title Priority Date Filing Date
CA069,922A Expired CA954512A (en) 1968-12-20 1969-12-15 5-phenyl-tetrazole derivatives

Country Status (9)

Country Link
US (1) US3665002A (de)
AT (3) AT294085B (de)
CA (1) CA954512A (de)
CH (1) CH535244A (de)
DE (1) DE1815922C3 (de)
FI (1) FI49619C (de)
FR (1) FR2026688B1 (de)
GB (1) GB1237790A (de)
NL (1) NL159974C (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2034986A1 (de) * 1970-07-15 1972-01-20 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof 4 Sulfamoyl m toluidin Derivate
DE2232457A1 (de) * 1972-07-01 1974-01-10 Boehringer Mannheim Gmbh Neue 3-alkyl-4-sulfamoylanilinderivate
US3991188A (en) * 1972-07-01 1976-11-09 Boehringer Mannheim G.M.B.H. 3-Alkyl-4-sulfamoyl-aniline therapeutic compositions
DE2423606A1 (de) * 1974-05-15 1975-11-27 Boehringer Mannheim Gmbh Pharmazeutisches praeparat
US3894033A (en) * 1974-05-16 1975-07-08 Pfizer 5-Aryltetrazoles
DE3034664A1 (de) * 1980-09-13 1982-05-06 Boehringer Mannheim Gmbh, 6800 Mannheim Verbessertes verfahren zur herstellung von 5-(4'-chlor-5'-sulfamoyl-2'-thenylamino)-phenyl-tetrazol
DE3041812A1 (de) * 1980-11-06 1982-06-16 Hoechst Ag, 6000 Frankfurt Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel
DE4228926A1 (de) * 1992-08-31 1994-03-03 Boehringer Mannheim Gmbh Spritzfertige Azosemid-Injektionslösungen
IT1288123B1 (it) 1996-09-04 1998-09-10 Nicox Sa Uso di nitroderivati per l'incontinenza urinaria
US7214711B2 (en) * 1998-12-23 2007-05-08 Neurotherapeutics Pharma Llc Method of treating migraine headache without aura
US8722668B2 (en) * 1998-12-23 2014-05-13 Daryl W. Hochman Methods and compositions for the treatment of neuropathic pain and neuropsychiatric disorders
US8008283B2 (en) * 1998-12-23 2011-08-30 Neurotherapeutics Pharma, Inc. Methods and compositions for the treatment of neuropsychiatric disorders
DE10112040A1 (de) * 2001-03-14 2002-10-02 Aventis Pharma Gmbh Verbessertes Verfahren zur Herstellung von Sulfonylcarboxamidderivaten
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
US20060063803A1 (en) * 2004-09-23 2006-03-23 Pfizer Inc 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds
US20080275093A1 (en) * 2004-11-15 2008-11-06 Nitromed, Inc. Diuretic Compounds Comprising Heterocyclic Nitric Oxide Donor Groups, Compositions and Methods of Use
WO2007047447A2 (en) * 2005-10-17 2007-04-26 Neurotherapeutics Pharma, Inc. Diuretic-like compound analogs useful for regulation of central nervous system disorders
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
WO2008070496A2 (en) 2006-12-01 2008-06-12 Bristol-Myers Squibb Company N- ( (3-benzyl) -2, 2- (bis-phenyl) -propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CN103096888B (zh) * 2011-08-08 2014-08-27 株式会社三和化学研究所 以氯唑噻磺胺为有效成分的包覆制剂
EP2887806B1 (de) 2012-07-20 2019-11-13 University Of Rochester Verfahren zur behandlung und vorbeugung von gehirnstörungen mit na+-k+-2ci-cotransporter-isoform 1-inhibitoren
CN105143203A (zh) 2013-04-17 2015-12-09 辉瑞大药厂 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
CN119060040A (zh) 2019-01-18 2024-12-03 阿斯利康(瑞典)有限公司 Pcsk9抑制剂及其使用方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1174797B (de) * 1962-10-16 1964-07-30 Hoechst Ag Verfahren zur Herstellung von Sulfamylanthranilsaeuren

Also Published As

Publication number Publication date
AT294084B (de) 1971-11-10
FI49619B (de) 1975-04-30
DE1815922A1 (de) 1970-06-25
GB1237790A (en) 1971-06-30
FI49619C (fi) 1975-08-11
NL159974B (nl) 1979-04-17
AT294085B (de) 1971-11-10
NL6919123A (de) 1970-06-23
FR2026688B1 (de) 1974-02-22
NL159974C (nl) 1979-09-17
DE1815922C3 (de) 1979-04-26
DE1815922B2 (de) 1978-08-03
FR2026688A1 (de) 1970-09-18
US3665002A (en) 1972-05-23
AT294086B (de) 1971-11-10
CH535244A (de) 1973-03-31

Similar Documents

Publication Publication Date Title
CA954512A (en) 5-phenyl-tetrazole derivatives
AU502845B2 (en) Eburnamenine derivatives
CA956312A (en) Quinuclidin-quinolinemethanol derivatives
CA781467A (en) Furochromone derivatives
CA944354A (en) Cycloalkano-quinolone derivatives
CA795330A (en) Dibenzocycloheptadiene-5-carboxamide derivatives
CA957382A (en) Azetidinol derivatives
CA945548A (en) 2-iminobenzodiazepine derivatives
CA801013A (en) 16-alkyl-progesterone derivatives
AU441802B2 (en) Indenopyridine derivatives
CA802903A (en) 1-aza-thiaxanthene derivatives
CA784728A (en) N-amino-nortropane derivatives
AU429809B2 (en) 5-nitrofuran derivatives
AU442136B2 (en) Benzothiopyranopyridine derivatives
AU431609B2 (en) Cycloalkano-quinolone derivatives
AU429548B2 (en) Diaryloxalamide derivatives
CA787928A (en) Aza-thiaxanthene derivatives
AU435189B2 (en) Phthaloyl-benzopyrrocoline derivatives
AU440270B2 (en) Diphenylmethoxyethylamino derivatives
CA781930A (en) Bromopyridazone derivatives
CA784232A (en) Thiaxanthene-1-oxide derivatives
CA785756A (en) Hydroretrocortin derivatives
CA786822A (en) Phenylcyclopropane derivatives
AU426865B2 (en) Benaodiazepine derivatives
CA789004A (en) Phenylcyclopropane derivatives